- Interlocutory injunctions remain a viable tool for patentees: Recent decisions confirm that originator pharmaceutical companies can still obtain interlocutory injunctions to restrain the launch of a first generic or biosimilar product, reversing the post-2018 trend against the grant
Stephanie Wang
Contact:Read more about Stephanie Wang
Who’s in control? Liability for copyright infringement by contractors and software developers
The High Court recently delivered its decision in Real Estate Tool Box v Campaigntrack 1 relating to copyright authorisation.
The High Court held that the appellants, who had engaged a third party software developer to create a real estate…